Beta Bionics, Inc. (BBNX)
16.75
-0.83
(-4.72%)
USD |
NASDAQ |
Oct 30, 16:00
16.73
-0.02
(-0.12%)
After-Hours: 20:00
Beta Bionics Cash from Operations (Quarterly) : -12.29M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -12.29M |
| June 30, 2026 | -14.62M |
| March 31, 2026 | -23.83M |
| December 31, 2025 | -8.627M |
| September 30, 2025 | -8.729M |
| June 30, 2025 | -13.59M |
| Date | Value |
|---|---|
| March 31, 2025 | -19.98M |
| December 31, 2024 | -14.28M |
| September 30, 2024 | -9.613M |
| June 30, 2024 | -12.24M |
| March 31, 2024 | -12.14M |
| December 31, 2023 | -6.347M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| PROCEPT BioRobotics Corp. | -19.25M |
| Edwards Lifesciences Corp. | 651.90M |
| Intuitive Surgical, Inc. | 1.224B |
| Stryker Corp. | 1.461B |
| Zimmer Biomet Holdings, Inc. | 447.80M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -114.08M |
| Cash from Financing (Quarterly) | 163.60M |
| Free Cash Flow | -65.96M |
| Free Cash Flow Per Share (Quarterly) | -0.3129 |
| Free Cash Flow to Equity (Quarterly) | -14.15M |
| Free Cash Flow to Firm (Quarterly) | -14.56M |
| Free Cash Flow Yield | -8.76% |